Physician Scientist, passion for science, a life devoted to patients care.
Joined May 2017
- Tweets 487
- Following 107
- Followers 248
- Likes 1,440
74 Photos and videos
Silvia Sookoian retweeted
New online! Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management dlvr.it/TRb1CM
2
55
128
7,820
22 Dec 2025
Agree! Emad has been an awesome EIC! Thank you Emad for your leadership and great work. Looking forward to the incoming editors. The team looks amazing.
22 Dec 2025
Words cannot really express how sad I am that @emadelomar is retiring - an absolute legend and someone I hugely admire not just as an EIC but as a person. Emad is simply the best! Looking forward to working with Bill, Matias and Thomas (BMT) - I am sure they will be amazing
1
2
5
2,508
Silvia Sookoian retweeted
4 Nov 2025
Semaglutide for #MASH - metabolic steatohepatitis @AghemoAlessio @SSookoian @LiverInt @policlinicoMI pubmed.ncbi.nlm.nih.gov/4114…
6
13
582
Silvia Sookoian retweeted
20 Jun 2025
Exciting news! "Clinical and Molecular Hepatology" has achieved a 2024 Impact Factor of 16.9, ranking 6th out of 143 in Gastrenterology & Hepatology.
Thank you all for your continued support and contributions. Let’s continue this journey together by advancing knowledge and driving impactful research!
#ResearchCommunity #ImpactFactor #CMH #KASL
1
4
22
897
Silvia Sookoian retweeted
16 May 2025
Avances en la enfermedad conocida como hígado graso.
Científicos del @CONICETDialoga y de UMAI identifican una proteína que asocia la esteatosis hepática, conocida como hígado graso, con complicaciones en órganos vitales. @SSookoian @ValeriaRoman @EduPeriodista @norabar
2
3
190
Silvia Sookoian retweeted
25 Apr 2025
Hoy, en la Academia Nacional de Medicina le entregamos el Doctorado Honoris Causa a Luis Acero, prestigioso médico español especialista en Cirugía Buco Maxilofacial. Participaron de esta ceremonia el Dr. Eduardo Rey, Adrián Giacchino, Lino Barañao, Tomás Ameigeiras y @SSookoian
1
2
3
174
Silvia Sookoian retweeted
With @ArunJSanyalVCU, @SSookoian, @cjpirola. A call to recognize MASLD/MASH as a NCD. #livertwitter New in @NatRevGastroHep
New online! MASLD as a non-communicable disease bit.ly/3WPHaz0
2
7
1,267
5 Jan 2025
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library onlinelibrary.wiley.com/doi/…
1
4
8
567
28 Dec 2024
Thank you for sharing this!
27 Dec 2024
#CGH4ALL📣💥
A complete and thorough review of genetics🧬& MASLD @AGA_CGH🔥!
🔗doi.org/10.1016/j.cgh.2024.0…
#MASLD #livertwitter #GITwitter
Reported by @ifrahfatima
@SSookoian
@lucavalenti75
@scottisaacsmd
@ArunJSanyalVCU
@BrettEFortuneMD
@Dr_Vijay_Shah
@DougSimonetto
@SanjayaSatapath
2
10
600
Silvia Sookoian retweeted
11 Dec 2024
Remember to screen first degree relatives for case finding of advanced #masld @stefano_romeo76 @SSookoian @NASH_and_coffee
11 Dec 2024
#CGH4ALL @AGA_CGH📣
In relatives of pts w/ adv. Fibrosis or HCC 2/2 MASLD:
💡56.8% MASLD Prevalence
💡14.4% adv fibrosis
DM🍭BMI🍐may be some common risk factors
Could not identify polygenic risk factors
🔗doi.org/10.1016/j.cgh.2023.1…
#LiverTwitter #MASLD
Report @talal_khurshid
6
13
1,419
10 Dec 2024
Awesome 🤩 @stefano_romeo76 . Absolutely agree. @lucavalenti75
9 Dec 2024
Our best work so far! nature.com/articles/s41591-0…
5
213
9 Dec 2024
👏🏻Congrats Federica, @stefano_romeo76 @lucavalenti75 and teamwork. Excellent work!!!
2
9
544
18 Jun 2024
Nice review! Congratulations @lucavalenti75 and team.
18 Jun 2024
ONLINE NOW: Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease dlvr.it/T8SJrt
7
356
11 Jun 2024
Thank you @NODGastro and Kerry, great EICs for this opportunity to share with you and some other talented people this awesome task.
1
5
519
Silvia Sookoian retweeted
6 Jun 2024
Never underestimate the gut microbiome's potential impact.
New @NatureMedicine
A younger metabolic age gut microbiome counters cardiovascular risk in older adults
nature.com/articles/s41591-0…
5
200
808
88,027
Silvia Sookoian retweeted
6 Jun 2024
The first drug approved for MASH, along with the global toll of this disease, summarized (e.g. ~30% of world population w/ MAFLD)
cell.com/cell/fulltext/S0092…
2
123
383
84,634
6 Jun 2024
Especialistas del CONICET analizan en <i>Cell</i> las perspectivas del primer fármaco para tratar la enfermedad del hígado graso en su estadio más avanzado conicet.gov.ar/especialistas…. Muchas gracias @CONICETDigital por compartir. Ciencia 🇦🇷 ! Agradecidos a @CellCellPress
1
199
6 Jun 2024
Resmetirom for treatment of MASH sciencedirect.com/science/ar… Honored by the invitation to summarize with @cjpirola this achievement from the biological perspective and implications. Thank you @CellCellPress and of course the brilliant team of the Resmetirom trial!
1
1
3
190
6 Jun 2024
Thank you patients and advocacy groups, and nurses and doctors who made this possible. @fattyliverday @FattyLiverA
1
127